Chapter 13 Equine Influenza Infection

  1. Wright PF, Webster RG: Orthomyxoviruses, Field's Virology, ed 4, Philadelphia, 2001, Lippincott-Raven.
  2. Ohwada K, Kitame F, Sugawara K, et al: Distribution of the antibody to influenza C virus in dogs and pigs in Yamagata Prefecture, Japan. Microbiol Immunol 31:1173–1180, 1987. PUBMED Abstract
  3. Manuguerra JC, Hannoun C, Simon F, et al: Natural infection of dogs by influenza C virus: a serological survey in Spain. New Microbiol 16:367–371, 1993. PUBMED Abstract
  4. Lamb R, Krug R: Orthomyxoviruses: the viruses and their replication, Field's Virology, ed 4, Philadelphia, 2001, Lippincott-Raven.
  5. Colman PM, Laver WG, Varghese JN, et al: Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 326:358–363, 1987. PUBMED Abstract
  6. Wilson IA, Skehel JJ, Wiley DC: Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289:366–373, 1981. PUBMED Abstract
  7. Mumford JA, Wood J, Chambers T: Consultation of OIE and WHO experts on progress in surveillance of equine influenza and application to vaccine strain selection. In Report of a meeting held at the Animal Health Trust, Newmarket, UK, 1995.
  8. Wharton SA, Weis W, Skehel JJ, et al: Structure, function, and antigenicity of the hemagglutinin of influenza virus, New York, 1989, Plenum Press.
  9. Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531–569, 2000. PUBMED Abstract
  10. Varghese JN, Laver WG, Colman PM: Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 303:35–40, 1983. PUBMED Abstract
  11. Gottschalk A: Neuraminidase: the specific enzyme of influenza virus and Vibrio cholerae. Biochim Biophys Acta 23(3):645–646, 1957. PUBMED Abstract
  12. Air GM, Laver WG: The neuraminidase of influenza virus. Proteins 6:341–356, 1989. PUBMED Abstract
  13. Bucher D, Palese P: The biologically active proteins of influenza virus: neuraminidase, New York, 1975, Academic Press.
  14. Palese P, Tobita K, Ueda M, et al: Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61:397–410, 1974. PUBMED Abstract
  15. Burnet F: Principles of animal virology, New York, 1969, Academic Press.
  16. Matrosovich MN, Matrosovich TY, Gray T, et al: Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78:12665–12667, 2004. PUBMED Abstract
  17. Pons MW, Schulze IT, Hirst GK, et al: Isolation and characterization of the ribonucleoprotein of influenza virus. Virology 39:250–259, 1969. PUBMED Abstract
  18. Hirst GK, Pons MW: Mechanism of influenza recombination. II. Virus aggregation and its effect on plaque formation by so-called noninfective virus. Virology 56:620–631, 1973. PUBMED Abstract
  19. Webster RG, Campbell CH, Granoff A: The �in vivo� production of �new� influenza viruses. 3. Isolation of recombinant influenza viruses under simulated conditions of natural transmission. Virology 51:149–162, 1973. PUBMED Abstract
  20. Fujii Y, Goto H, Watanabe T, et al: Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci USA 100:2002–2007, 2003. PUBMED Abstract
  21. Gorman OT, Bean WJ, Kawaoka Y, et al: Evolution of influenza A virus nucleoprotein genes: implications for the origins of H1N1 human and classical swine viruses. J Virol 65:3704–3714, 1991. PUBMED Abstract
  22. Horimoto T, Kawaoka Y: Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 14:129–149, 2001. PUBMED Abstract
  23. Ito T, Kawaoka Y: Avian influenza, Oxford, 1998, Blackwell Science.
  24. Ito T, Kawaoka Y: Host-range barrier of influenza A viruses. Vet Microbiol 74:71–75, 2000. PUBMED Abstract
  25. Gammelin M, Mandler J, Scholtissek C: Two subtypes of nucleoproteins (NP) of influenza A viruses. Virology 170:71–80, 1989. PUBMED Abstract
  26. Webster RG: Influenza: an emerging disease. Emerg Infect Dis 4:436–441, 1998. PUBMED Abstract
  27. Webster RG, Bean WJ, Gorman OT, et al: Evolution and ecology of influenza A viruses. Microbiol Rev 56:152–179, 1992. PUBMED Abstract
  28. Olsen CW: The emergence of novel swine influenza viruses in North America. Virus Res 85:199–210, 2002. PUBMED Abstract
  29. Subbarao K, Swayne D, Olsen CW: Epidemiology and control of human and animal influenza, Norfalk, UK, 2004, Caister Academic Press.
  30. Webby RJ, Webster RG: Emergence of influenza A viruses. Philos Trans R Soc B Biol Sci 356:1817–1828, 2001. PUBMED Abstract
  31. Tumova B: Equine influenza: a segment in influenza virus ecology. Comp Immunol Microbiol Infect Dis 3:45–59, 1980. PUBMED Abstract
  32. Alexander DJ, Brown IH: Recent zoonoses caused by influenza A viruses. Rev Scientif Techniq 19:197–225, 2000. PUBMED Abstract
  33. Chirnside E, Sinclair R, Mumford J: Respiratory viral diseases, Philadelphia, 1998, Saunders.
  34. Coggins L: Viral respiratory disease. Vet Clin North Am Large Anim Pract 1:59–72, 1979. PUBMED Abstract
  35. Powell DG: Viral respiratory disease of the horse. Vet Clin North Am Equine Pract 7:27–52, 1991. PUBMED Abstract
  36. Sovinova O, Tumova B, Pouska F, et al: Isolation of a virus causing respiratory disease in horses. Acta Virol 2(1):52–61, 1958. PUBMED Abstract
  37. Van Maanen C, Cullinane A: Equine influenza virus infections: an update. Vet Q 24:79–94, 2002. PUBMED Abstract
  38. Webster RG: Are equine 1 influenza viruses still present in horses? Equine Vet J 25:537–538, 1993. PUBMED Abstract
  39. Lai AC, Chambers TM, Holland RE Jr, et al: Diverged evolution of recent equine-2 influenza (H3N8) viruses in the Western Hemisphere. Arch Virol 146:1063–1074, 2001. PUBMED Abstract
  40. Oxburgh L, Klingeborn B: Cocirculation of two distinct lineages of equine influenza virus subtype H3N8. J Clin Microbiol 37:3005–3009, 1999. PUBMED Abstract
  41. Watson J, Halpin K, Selleck P, et al: Isolation and characterization of an H3N8 equine influenza virus in Australia, 2007. Aust Vet J 89:35–37, 2011. PUBMED Abstract
  42. Yamanaka T, Niwa H, Tsujimura K, et al: Epidemic of equine influenza among vaccinated racehorses in Japan in 2007. J Vet Med Sci 70:623–625, 2008. PUBMED Abstract
  43. Callinan I: Equine influenza: the August 2007 oubreak in Australia. Report of the Equine Influenza Inquiry, April 23, 2008.
  44. Garner MG, Scanlan WA, Cowled BD, et al: Regaining Australia's equine influenza-free status: a national perspective. Aust Vet J 89:169–173, 2011. PUBMED Abstract
  45. Scott-Orr H: Proof of freedom from equine influenza infection in Australia in 2007-08. Aust Vet J 89:163–164, 2011. PUBMED Abstract
  46. Guthrie AJ, Stevens KB, Bosman PP: The circumstances surrounding the outbreak and spread of equine influenza in South Africa. Rev Scientif Techniq 18:179–185, 1999. PUBMED Abstract
  47. Uppal PK, Yadav MP: Outbreak of equine influenza in India. Vet Rec 121:569–570, 1987. PUBMED Abstract
  48. Uppal PK, Yadav MP, Oberoi MS: Isolation of A/Equi-2 virus during 1987 equine influenza epidemic in India. Equine Vet J 21:364–366, 1989. PUBMED Abstract
  49. Guo Y, Wang M, Kawaoka Y, et al: Characterization of a new avian-like influenza A virus from horses in China. Virology 188:245–255, 1992. PUBMED Abstract
  50. Guo YJ, Wang M, Zheng GS, et al: Presented at the Equine infectious diseases VII: Proceedings of the Seventh International Conference, Tokyo, 1994.
  51. Shortridge KF, Chan WH, Guan Y: Epidemiology of the equine influenza outbreak in China, 1993-94. Vet Rec 136:160–161, 1995. PUBMED Abstract
  52. Kawaoka Y, Bean WJ, Webster RG: Evolution of the hemagglutinin of equine H3 influenza viruses. Virology 169:283–292, 1989. PUBMED Abstract
  53. Guthrie AJ: Presented at the 9th International Congress of World Equine Veterinary Association, 2006.
  54. Daly JM, Lai AC, Binns MM, et al: Antigenic and genetic evolution of equine H3N8 influenza A viruses. J Gen Virol 77:661–671, 1996. PUBMED Abstract
  55. Ozaki H, Shimizu-Nei A, Sugita S, et al: Antigenic variation among equine H3N 8 influenza virus hemagglutinins. Jpn J Vet Res 48:177–186, 2001. PUBMED Abstract
  56. Bryant NA, Rash AS, Russell CA, et al: Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet Microbiol 138:41–52, 2009. PUBMED Abstract
  57. Daly JM, MacRae S, Newton JR, et al: Equine influenza: a review of an unpredictable virus. Vet J 189:4–14, 2011. PUBMED Abstract
  58. Damiani AM, Scicluna MT, Ciabatti I, et al: Genetic characterization of equine influenza viruses isolated in Italy between 1999 and 2005. Virus Res 131:100–105, 2008. PUBMED Abstract
  59. Rozek W, Purzycka M, Polak MP, et al: Genetic typing of equine influenza virus isolated in Poland in 2005 and 2006. Virus Res 145:121–126, 2009. PUBMED Abstract
  60. Morley PS, Townsend HGG, Bodgan JR, et al: Descriptive epidemiologic study of disease associated with influenza virus infections during three epidemics in horses. J Am Vet Med Assoc 216:535–544, 2000. PUBMED Abstract
  61. Mumford EL, Traub-Dargatz J, Carman J, et al: Occurrence of infectious upper respiratory tract disease and response to vaccination in horses on six sentinel premises in northern Colorado. Equine Vet J 35:72–77, 2003. PUBMED Abstract
  62. Sherman J, Mitchell WR, Martin SW, et al: Epidemiology of equine upper respiratory tract disease on Standardbred racetracks. Can J Comp Med 43:1–9, 1979. PUBMED Abstract
  63. Happold J, Rubira R: Equine influenza: patterns of disease and seroprevalence in Thoroughbred studs and implications for vaccination. Aust Vet J 89:135–137, 2011. PUBMED Abstract
  64. Nyaga PN, Wiggins AD, Priester WA: Epidemiology of equine influenza, risk by age, breed and sex. Comp Immunol Microbiol Infect Dis 3:67–73, 1980. PUBMED Abstract
  65. Virmani N, Bera BC, Gulati BR, et al: Descriptive epidemiology of equine influenza in India (2008-2009): temporal and spatial trends. Veterinaria Italiana 46:449–458, 2010. PUBMED Abstract
  66. Peek SF, Landolt G, Karasin AI, et al: Acute respiratory distress syndrome and fatal interstitial pneumonia associated with equine influenza in an neonatal foal. J Vet Intern Med 18:132–134, 2004. PUBMED Abstract
  67. Smith BP: Influenza in foals. J Am Vet Med Assoc 174:289–290, 1979. PUBMED Abstract
  68. Morley PS, Townsend HGG, Bodgan JR, et al: Risk factors for disease associated with influenza virus infections during three epidemics in horses. J Am Vet Med Assoc 216:545–550, 2000. PUBMED Abstract
  69. Morley P: Viral respiratory disease in athletic horses. In Hinchcliff KW, Kaneps AJ, Geor RJ, editors: Equine sports medicine and surgery: basic and clinical sciences of the equine athlete, London, 2004, Saunders, Elsevier Science, pp 657–673.
  70. Heldens JG, Weststrate MW, van den Hoven R: Area under the curve calculations as a tool to compare the efficacy of equine influenza vaccines: a retrospective analysis of three independent field trials. J Immunol Methods 264:1–17, 2002. PUBMED Abstract
  71. Mumford JA, Wilson H, Hannant D, et al: Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant. Epidemiol Infect 112:421–437, 1994. PUBMED Abstract
  72. Mumford JA, Wood JM, Folkers C, et al: Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus. Epidemiol Infect 100:501–510, 1988. PUBMED Abstract
  73. Mumford J, Wood JM, Scott AM, et al: Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). J Hygiene 90:385–395, 1983. PUBMED Abstract
  74. Newton JR, Townsend HG, Wood JL, et al: Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 32:65–74, 2000. PUBMED Abstract
  75. Hannant D, Mumford JA, Jessett DM: Duration of circulating antibody and immunity following infection with equine influenza virus. Vet Rec 122:125–128, 1988. PUBMED Abstract
  76. Garcia-Sastre A: Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279:375–384, 2001. PUBMED Abstract
  77. Townsend HGG, Lunn DP, Bogdan J, et al: Comparative efficacy of commercial vaccines in naive horses: serologic responses and protection after influenza challenge. Paper presented at 49th Annual AAEP Convention, American Association of Equine Practitioners, New Orleans, 2003.
  78. Townsend HG, Penner SJ, Watts TC, et al: Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet J 33:637–643, 2001. PUBMED Abstract
  79. Crouch CF, Daly J, Hannant D, et al: Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an �American lineage� H3N8 virus. Vaccine 23:418–425, 2004. PUBMED Abstract
  80. Heldens JG, Pouwels HG, Loon AA: Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95). Vet J 167:150–157, 2004. PUBMED Abstract
  81. Soboll G, Horohov DW, Aldridge BM, et al: Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet Immunol Immunopathol 94:47–62, 2003. PUBMED Abstract
  82. Kastner SB, Haines DM, Archer J, et al: Investigations on the ability of clenbuterol hydrochloride to reduce clinical signs and inflammation associated with equine influenza A infection. Equine Vet J 31:160–168, 1999. PUBMED Abstract
  83. Liu KK: Report of an equine influenza outbreak which occurred in Hong Kong. Bull Office Int Epizoot 105:116–117, 1993.
  84. Newton JR, Verheyen K, Wood JL, et al: Equine influenza in the United Kingdom in 1998. Vet Rec 145:449–452, 1999. PUBMED Abstract
  85. Sarasola P, Taylor DJ, Love S, et al: Secondary bacterial infections following an outbreak of equine influenza. Vet Rec 131:441–442, 1992. PUBMED Abstract
  86. Austin SM, Foreman JH, Hungerford LL: Case-control study of risk factors for development of pleuropneumonia in horses. J Am Vet Med Assoc 207:325–330, 1995. PUBMED Abstract
  87. Barr BS: Pneumonia in weanlings. Vet Clin North Am Equine Pract 19:35–49, 2003. PUBMED Abstract
  88. Mumford JA, Hannant D, Jessett DM: Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Equine Vet J 22:93–98, 1990. PUBMED Abstract
  89. Guo YJ, Guo ZM, Zhang SL, et al: Occurrence of equine influenza in epidemic form in Northeast China. Virus Information Exchange Newslett South East Asia West Pacific 6:129, 1989.
  90. Guo Y, Wang M, Zheng S, et al: Aetiologic study of an influenza-like epidemic in horses in China. Acta Virol 35:190–195, 1991. PUBMED Abstract
  91. Powell DG, Watkins KL, Li PH, et al: Outbreak of equine influenza among horses in Hong Kong during 1992. Vet Rec 136:531–536, 1995. PUBMED Abstract
  92. Bendixen PH, Emanuelson U, Forssberg P, et al: Analysis of status of vaccination and development of fever in trotters in Sweden during an outbreak of influenza type A2 (H3N8). Prev Vet Med 16:95–102, 1993.
  93. Bendixen PH, Forssberg P, Silfverberg L: Vaccination status and fever in trotting horses in relation to influenza outbreaks in spring 1991. Svensk Vet 43:713–715, 1991.
  94. Gudding R, Johansen GI: The significance of age and vaccination interval on the protection of horses against equine influenza. Norsk Veterinaertidsskrift 102:35–36, 1990.
  95. Wood J, Mumford J: Epidemiology of equine influenza. Vet Rec 130:126, 1992. PUBMED Abstract
  96. Bridges CB, Kuehnert MJ, Hall CBH: Transmission of influenza: implications for control in health care settings. Clin Infect Dis 37:1094–1101, 2003. PUBMED Abstract
  97. Boone SA, Gerba CP: The occurrence of influenza A virus on household and day care center fomites. J Infect 51:103–109, 2005. PUBMED Abstract
  98. Hota B: Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 39:1182–1189, 2004. PUBMED Abstract
  99. Daly JM, Yates PJ, Newton JR, et al: Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines. Vaccine 22:4101–4109, 2004. PUBMED Abstract
  100. Daly JM, Newton JR, Mumford JA: Current perspectives on control of equine influenza. Vet Res 35:411–423, 2004. PUBMED Abstract
  101. Lany P, Pospisil Z, Zendulkova D, et al: An epidemiological study on an outbreak of equine influenza in the Czech Republic in the autumn of 1995. Vet Med 42:39–42, 1997. PUBMED Abstract
  102. Higgins WP, Gillespie JH, Holmes DF, Robson DS: Surveys of equine influenza outbreaks during 1983 and 1984. J Equine Vet Sci 6:15–19, 1986.
  103. Timoney PJ: Equine influenza. Comp Immunol Microbiol Infect Dis 19:205–211, 1996. PUBMED Abstract
  104. Wilson WD: Equine influenza. Vet Clin North Am Equine Pract 9:257–282, 1993. PUBMED Abstract
  105. Firestone SM, Ward MP, Christley RM, et al: The importance of location in contact networks: Describing early epidemic spread using spatial social network analysis. Preventive Veterinary Medicine 102:185–195, 2011. PUBMED Abstract
  106. Cowled B, Ward MP, Hamilton S, et al: The equine influenza epidemic in Australia: spatial and temporal descriptive analyses of a large propagating epidemic. Preventive Veterinary Medicine 92:60–70, 2009. PUBMED Abstract
  107. Firestone SM, Christley RM, Ward MP, et al: Adding the spatial dimension to the social network analysis of an epidemic. In Fourichon C, Pfeiffer DU, editors: Proceedings of the Society for Veterinary Epidemiology and Preventive Medicine, Leipzig, Germany, 23rd-25th March 2011. Society for Veterinary Epidemiology and Preventive Medicine, Roslin; UK. pp 171–181.
  108. Moloney BJ: Overview of the epidemiology of equine influenza in the Australian outbreak. Aust Vet J 89:50–56, 2011. PUBMED Abstract
  109. Kung N, Mackenzie S, Pitt D, et al: Significant features of the epidemiology of equine influenza in Queensland, Australia, 2007. Aust Vet J 89:78–85, 2007.
  110. Moloney B, Sergeant ESG, Taragel C, et al: Significant features of the epidemiology of equine influenza in New South Wales, Australia, 2007. Aust Vet J 89:56–63, 2011.
  111. Morton JM, Dups JN, Anthony ND, et al: Epidemic curve and hazard function for occurrence of clinical equine influenza in a closed population of horses at a 3-day event in southern Queensland, Australia, 2007. Aust Vet J 89:86–88, 2007.
  112. Gilkerson JR: Equine influenza in Australia: a clinical overview. Aust Vet J 89:11–13, 2011 PUBMED Abstract
  113. Firestone SM, Schemann KA, Toribio J-ALML, et al: A case-control study of risk factors for equine influenza spread onto horse premises during the 2007 epidemic in Australia. Prev Vet Med 100:53–63, 2011. PUBMED Abstract
  114. Sato SB, Kawasaki K, Ohnishi S: Hemolytic activity of influenza virus hemagglutinin glycoproteins activated in mildly acidic environments. Proc Natl Acad Sci USA 80:3153–3157, 1983. PUBMED Abstract
  115. White J, Matlin K, Helenius A: Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol 89:674–679, 1981. PUBMED Abstract
  116. Whittaker GR, Helenius A: Nuclear import and export of viruses and virus genomes. Virology 246:1–23, 1998. PUBMED Abstract
  117. Donelan NR, Basler CF, Garcia-Sastre A: A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77:13257–13266, 2003. PUBMED Abstract
  118. Krug RM, Yuan W, Noah DL, Latham AG: Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309:181–189, 2003. PUBMED Abstract
  119. Boulan ER, Sabatini DD: Asymmetric budding of viruses in epithelial monolayers: a model system for study of epithelial polarity. Proc Natl Acad Sci USA 75:5071–5075, 1978. PUBMED Abstract
  120. Rudneva IA, Kovaleva VP, Varich NL, et al: Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation. Arch Virol 133:437–450, 1993. PUBMED Abstract
  121. Jin H, Leser GP, Lamb RA: The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J 13:5504–5515, 1994. PUBMED Abstract
  122. Jin H, Leser GP, Zhang J, et al: Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J 16:1236–1247, 1997. PUBMED Abstract
  123. Cullinane AA: Viral respiratory disease, ed 4, Philadelphia, 1997, Saunders.
  124. Lin C, Holland RE Jr, Donofrio JC, et al: Caspase activation in equine influenza virus induced apoptotic cell death. Vet Microbiol 84:357–365, 2002. PUBMED Abstract
  125. Lin C, Zimmer SG, Lu Z, et al: The involvement of a stress-activated pathway in equine influenza virus–mediated apoptosis. Virology 287:202–213, 2001. PUBMED Abstract
  126. Schultz-Cherry S, Dybdahl-Sissoko N, Neumann G, et al: Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol 75:7875–7881, 2001. PUBMED Abstract
  127. Martin CM, Kunin CM, Gottlieb LS, et al: Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases. Arch Intern Med 103(4):515–531, 1959. PUBMED Abstract
  128. Gerber H: Clinical features, sequelae and epidemiology of equine influenza, New York, 1969, Karger.
  129. Willoughby R, Ecker G, McKee S, et al: The effects of equine rhinovirus, influenza virus and herpesvirus infection on tracheal clearance rate in horses. Can J Vet Res 56:115–121, 1992. PUBMED Abstract
  130. Mulder J, Hers JF: Influenza, Groningen, The Netherlands, 1979, Wolters-Noordhoff.
  131. Hall WJ, Douglas RG Jr, Hyde RW, et al: Pulmonary mechanics after uncomplicated influenza A infection. Am Rev Respir Dis 113:141–148, 1976. PUBMED Abstract
  132. Daly JM, Whitwell KE, Miller J, et al: Investigation of equine influenza cases exhibiting neurological disease: coincidence or association? J Comp Pathol 134:231–235, 2006. PUBMED Abstract
  133. Durando MM, Birks EK, Hussey SB, et al: Cardiac troponin I concentrations in ponies challenged with equine influenza virus. J Vet Intern Med 25:339–344, 2011. PUBMED Abstract
  134. Yao D, Kuwajima M, Kido H: Pathologic mechanisms of influenza encephalitis with an abnormal expression of inflammatory cytokines and accumulation of mini-plasmin. J Med Invest 50:1–8, 2003. PUBMED Abstract
  135. Gross DK, Hinchcliff KW, French PS, et al: Effect of moderate exercise on the severity of clinical signs associated with influenza virus infection in horses. Equine Vet J 30:489–497, 1998. PUBMED Abstract
  136. Newton JR, Mumford JA: Equine influenza. In Coetzer JAW, Tustin RC, editors: Infectious diseases of livestock, Oxford, 2005, Oxford University Press, pp 766–774.
  137. Wattrang E, Jessett DM, Yates P, et al: Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. Viral Immunol 16:57–67, 2003. PUBMED Abstract
  138. Hannant D, Jessett DM, O'Neill T, et al: Antibody isotype responses in the serum and respiratory tract to primary and secondary infections with equine influenza virus (H3N8). Vet Microbiol 19:293–303, 1989. PUBMED Abstract
  139. Nelson KM, Schram BR, McGregor MW, et al: Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 16:1306–1313, 1998. PUBMED Abstract
  140. Renegar KB, Small PAJ: Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol 146:1972–1978, 1991. PUBMED Abstract
  141. Tomoda T, Morita H, Kurashige T, et al: Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-gamma production and local IgA response. Vaccine 13:185–190, 1995. PUBMED Abstract
  142. Mazanec MB, Coudret CL, Fletcher DR: Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 69:1339–1343, 1995. PUBMED Abstract
  143. Mazanec MB, Kaetzel CS, Lamm ME, et al: Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 89:6901–6905, 1992. PUBMED Abstract
  144. Mazanec MB, Nedrud JG, Kaetzel CS, et al: A three-tiered view of the role of IgA in mucosal defense. Immunol Today 14:430–435, 1993. PUBMED Abstract
  145. Mazanec MB, Lamm ME, Lyn D, et al: Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res 23:1–12, 1992. PUBMED Abstract
  146. Soboll G, Nelson KM, Leuthner ES, et al: Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response. Vaccine 21:3081–3092, 2003. PUBMED Abstract
  147. Lunn DP, Soboll G, Schram BR, et al: Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 17:2245–2258, 1999. PUBMED Abstract
  148. Breathnach CC, Yeargan MR, Sheoran AS, et al: The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. Equine Vet J 33:651–657, 2001. PUBMED Abstract
  149. Sheoran AS, Sponseller BT, Holmes MA, et al: Serum and mucosal antibody isotype responses to M-like protein (SeM) of Streptococcus equi in convalescent and vaccinated horses. Vet Immunol Immunopathol 59:239–251, 1997. PUBMED Abstract
  150. Morley PS, Hanson LK, Bogdan JR, et al: The relationship between single radial hemolysis, hemagglutination inhibition, and virus neutralization assays used to detect antibodies specific for equine influenza viruses. Vet Microbiol 45:81–92, 1995. PUBMED Abstract
  151. Lunn DP, Hussey S, Sebring R, et al: Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in horses after induction of exercise-induced immunosuppression. J Am Vet Med Assoc 218:900–906, 2001. PUBMED Abstract
  152. Fu TM, Friedman A, Ulmer JB, et al: Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J Virol 71:2715–2721, 1997. PUBMED Abstract
  153. Ulmer JB, Fu TM, Deck RR, et al: Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J Virol 72:5648–5653, 1998. PUBMED Abstract
  154. Hannant D, Mumford JA: Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells. Vet Immunol Immunopathol 21:327–337, 1989. PUBMED Abstract
  155. Murali-Krishna K, Altman JD, Suresh M, et al: In vivo dynamics of anti-viral CD8 T cell responses to different epitopes: an evaluation of bystander activation in primary and secondary responses to viral infection. Adv Exp Med Biol 452:123–142, 1998. PUBMED Abstract
  156. Sun Y, Iglesias E, Samri A, et al: A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J Immunol Methods 272:23–34, 2003. PUBMED Abstract
  157. Breathnach CC, Clark HJ, Clark RC, et al: Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine 24:1180–1190, 2005. PUBMED Abstract
  158. Breathnach CC, Rudersdorf R, Lunn DP: Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination. Vet Immunol Immunopathol 98:127–136, 2004. PUBMED Abstract
  159. Toulemonde CE, Daly J, Sindle T, et al: Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet Rec 156:367–371, 2005. PUBMED Abstract
  160. Chen Z, Yoshikawa T, Kadowaki S, et al: Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein. J Gen Virol 80:2559–2564, 1999. PUBMED Abstract
  161. Ulmer JB, Donnelly JJ, Parker SE, et al: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749, 1993. PUBMED Abstract
  162. Boivin G, Hardy I, Kress A: Evaluation of a rapid optical immunoassay for influenza viruses (FLU OIA test) in comparison with cell culture and reverse transcription-PCR. J Clin Microbiol 39:730–732, 2001. PUBMED Abstract
  163. Ellis JS, Fleming DM, Zambon MC: Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol 35:2076–2082, 1997. PUBMED Abstract
  164. Fouchier RA, Bestebroer TM, Herfst S, et al: Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol 38:4096–4101, 2000. PUBMED Abstract
  165. Mumford JA: The diagnosis and control of equine influenza. Proc Am Assoc Equine Pract 36:377, 1990. PUBMED Abstract
  166. Endo Y, Carroll KN, Ikizler MR, et al: Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J Virol 70:2055–2058, 1996. PUBMED Abstract
  167. Frank AL, Couch RB, Griffis CA, et al: Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses. J Clin Microbiol 10:32–36, 1979.
  168. Lau SC, Scholtissek C: Abortive infection of Vero cells by an influenza A virus (FPV). Virology 212:225–231, 1995. PUBMED Abstract
  169. Reina J, Fernandez-Baca V, Blanco I, et al: Comparison of Madin-Darby canine kidney cells (MDCK) with a green monkey continuous cell line (Vero) and human lung embryonated cells (MRC-5) in the isolation of influenza A virus from nasopharyngeal aspirates by shell vial culture. J Clin Microbiol 35:1900–1901, 1997. PUBMED Abstract
  170. Huang YT, Turchek BM: Mink lung cells and mixed mink lung and A549 cells for rapid detection of influenza virus and other respiratory viruses. J Clin Microbiol 38:422–423, 2000. PUBMED Abstract
  171. Hannant D, Mumford JA: Equine influenza, St Louis, 1996, Elsevier Science.
  172. Landolt GA, Karasin AI, Hofer C, et al: Use of real-time reverse transcriptase polymerase chain reaction assay and cell culture methods for detection of swine influenza A viruses. Am J Vet Res 66:119–124, 2005. PUBMED Abstract
  173. Schultz-Cherry S, Dybdahl-Sissoko N, McGregor M, et al: Mink lung epithelial cells: unique cell line that supports influenza A and B virus replication. J Clin Microbiol 36:3718–3720, 1998. PUBMED Abstract
  174. Chomel JJ, Thouvenot D, Onno M, et al: Rapid diagnosis of influenza infection of NP antigen using an immunocapture ELISA test. J Virol Methods 25:81–91, 1989. PUBMED Abstract
  175. Cook RF, Sinclair R, Mumford JA: Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses. J Virol Methods 20:1–12, 1988. PUBMED Abstract
  176. Livesay GJ, O'Neill T, Hannant D, et al: The outbreak of equine influenza (H3N8) in the United Kingdom in 1989: diagnostic use of an antigen capture ELISA. Vet Rec 133:515–519, 1993. PUBMED Abstract
  177. Adam EN, Morley PS, Chmielewski KE, et al: Detection of cold-adapted vaccine-strain influenza virus using two commercial assays. Equine Vet J 34:400–404, 2002. PUBMED Abstract
  178. Chambers TM, Shortridge KF, Li PH, et al: Rapid diagnosis of equine influenza by the Directigen FLU-A enzyme immunoassay. Vet Rec 135:275–279, 1994. PUBMED Abstract
  179. Morley PS, Bogdan JR, Townsend HG, Haines DM: Evaluation of Directigen Flu-A assay for detection of influenza antigen in nasal secretions of horses. Equine Vet J 27:131–134, 1995. PUBMED Abstract
  180. Quinlivan M, Cullinane A, Nelly M, et al: Comparison of sensitivities of virus isolation, antigen detection, and nucleic acid amplification for detection of equine influenza virus. J Clin Microbiol 42:759–763, 2004. PUBMED Abstract
  181. Townsend HGG, Moore SL, Bogdan JR: Evaluation of an optical immunoassay for the diagnosis of equine influenza. In Proceedings of the 9th Symposium of the International Society for Veterinary Epidemiology and Economics, 2000.
  182. Herrmann B, Larsson C, Zweygberg BW: Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription–PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 39:134–138, 2001. PUBMED Abstract
  183. Bej AK, Mahbubani MH, Atlas RM: Amplification of nucleic acids by polymerase chain reaction (PCR) and other methods and their applications. Crit Rev Biochem Mol Biol 26:301–334, 1991. PUBMED Abstract
  184. Wagar EA: Direct hybridization and amplification applications for the diagnosis of infectious diseases. J Clin Lab Anal 10:312–325, 1996. PUBMED Abstract
  185. Wolcott MJ: Advances in nucleic acid–based detection methods. Clin Microbiol Rev 5:370–386, 1992.
  186. Magnard C, Valette M, Aymard M, et al: Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses. J Med Virol 59:215–220, 1999. PUBMED Abstract
  187. Wallace LA, McAulay KA, Douglas JD, et al: Influenza diagnosis: from dark isolation into the molecular light, West of Scotland Respiratory Virus Study Group. J Infection 39:221–226, 1999. PUBMED Abstract
  188. Spackman E, Senne DA, Myers TJ, et al: Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 40:3256–3260, 2002. PUBMED Abstract
  189. Diallo IS, Read AJ, Kirkland PD: Potential of vaccination to confound interpretation of real-time PCR results for equine influenza. Vet Rec 169:252–252, 2011. PUBMED Abstract
  190. Jackson DP, Hayden JD, Quirke P: Extraction of nucleic acid from fresh and archival material, Oxford, UK, 1991, Oxford University Press.
  191. Steininger C, Kundi M, Aberle SW, et al: Effectiveness of reverse transcription-PCR, virus isolation, and enzyme-linked immunosorbent assay for diagnosis of influenza A virus infection in different age groups. J Clin Microbiol 40:2051–2056, 2002. PUBMED Abstract
  192. Al-Soud WA, Radstrom P: Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol 39:485–493, 2001. PUBMED Abstract
  193. Habib-Bein NF, Beckwith WH 3rd, et al: Comparison of SmartCycler real-time reverse transcription–PCR assay in a public health laboratory with direct immunofluorescence and cell culture assays in a medical center for detection of influenza A virus. J Clin Microbiol 41:3597–3601, 2003. PUBMED Abstract
  194. Stauffer F, Haber H, Rieger A, et al: Genus level identification of mycobacteria from clinical specimens by using an easy-to-handle Mycobacterium-specific PCR assay. J Clin Microbiol 36:614–617, 1998. PUBMED Abstract
  195. Zou S: A practical approach to genetic screening for influenza virus variants. J Clin Microbiol 35:2623–2627, 1997. PUBMED Abstract
  196. Zou S, Stansfield C, Bridge J: Identification of new influenza B virus variants by multiplex reverse transcription–PCR and the heteroduplex mobility assay. J Clin Microbiol 36:1544–1548, 1998. PUBMED Abstract
  197. Dynon K, Varrasso A, Ficorilli N, et al: Identification of equine herpesvirus 3 (equine coital exanthema virus), equine gammaherpesviruses 2 and 5, equine adenoviruses 1 and 2, equine arteritis virus and equine rhinitis A virus by polymerase chain reaction. Aust Vet J 79:695–702, 2001. PUBMED Abstract
  198. Foord AJ, Selleck P, Colling A, et al: Real-time RT-PCR for detection of equine influenza and its evaluation using samples from horses infected with A/equine/Sydney/2007 (H3N8). Aust Vet J 89:37–38, 2009. PUBMED Abstract
  199. Pusterla N, Madigan JE, Leutenegger CM: Real-time polymerase chain reaction: a novel molecular diagnostic tool for equine infectious diseases. J Vet Intern Med 20:3–12, 2006. PUBMED Abstract
  200. Soboll G, Hussey SB, Minke JM, et al: Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC�) vaccination. Vet Immunol Immunopathol 135:100–107, 2010. PUBMED Abstract
  201. Mumford J: Progress in the control of influenza, Newmarket, UK, 1991, R&W Publications.
  202. Wood JM, Gaines-Das RE, Taylor J, et al: Comparison of influenza serological techniques by international collaborative study. Vaccine 12:167–174, 1994. PUBMED Abstract
  203. Flint SJ, Enquist LW, Krug RM, et al: Virus cultivation, detection and genetics, Washington, DC, 2000, ASM Press.
  204. Hamilton F: Studies on the single radial hemolysis technique for the assay of equine influenza virus, adenovirus and herpesvirus 1 antibodies, Princeton, NJ, 1978, Veterinary Publications.
  205. Plateau E, Cruciere C: Study on radial hemolysis method for the detection of anti influenza equi antibodies in equine sera: reliability and expression of the results. Zentralblatt Vet Reihe B 30:512–520, 1983. PUBMED Abstract
  206. Garin B, Plateau E, Gillet-Forin S: Serological diagnosis of influenza A infections in the horse by enzyme immunoassay: comparison with the complement fixation test. Vet Immunol Immunopathol 13:357–363, 1986. PUBMED Abstract
  207. Sugiura T, Sugita S, Imagawa H, et al: Serological diagnosis of equine influenza using the hemagglutinin protein produced in a baculovirus expression system. J Virol Methods 98:1–8, 2001. PUBMED Abstract
  208. Ozaki H, Sugiura T, Sugita S, et al: Detection of antibodies to the nonstructural protein (NS1) of influenza A virus allows distinction between vaccinated and infected horses. Vet Microbiol 82:111–119, 2001. PUBMED Abstract
  209. Birch-Machin I, Rowan A, Pick J, et al: Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera. J Virol Methods 65:255–263, 1997. PUBMED Abstract
  210. Nakajima K, Nobusawa E, Nakajima S: Evolution of the NS genes of the influenza A viruses. II. Characteristics of the amino acid changes in the NS1 proteins of the influenza A viruses. Virus Genes 4:15–26, 1990. PUBMED Abstract
  211. Kirkland PD, Delbridge G: Use of a blocking ELISA for antibodies to equine influenza virus as a test to distinguish between naturally infected and vaccinated horses: proof of concept studies. Aust Vet J 89:45–46, 2011. PUBMED Abstract
  212. Perkins NR, Webster RG, Wright T, et al: Vaccination program in the response to the 2007 equine influenza outbreak in Australia. Aust Vet J 89:126–134, 2011. PUBMED Abstract
  213. Kirkland PD: Role of the diagnostic laboratories during the 2007 equine influenza outbreak in Australia. Aust Vet J 89:29–32, 2011. PUBMED Abstract
  214. Sergeant ESG, Cowled BD, Bingham P: Diagnostic specificity of an equine influenza blocking ELISA estimated from New South Wales field data from the Australian epidemic in 2007. Aust Vet J 89:43–45, 2011. PUBMED Abstract
  215. Begg AP, Reece RL, Hum S, et al: Pathological changes in horses dying with equine influenza in Australia, 2007. Aust Vet J 89:19–22, 2007.
  216. Britton AP, Robinson JH: Isolation of influenza A virus from a 7-day-old foal with bronchointerstitial pneumonia. Can Vet J 43:55–56, 2002. PUBMED Abstract
  217. Patterson-Kane JC, Carrick JB, Axon JE, et al: The pathology of bronchointerstitial pneumonia in young foals associated with the first outbreak of equine influenza in Australia. Equine Vet J 40:199–203, 2008. PUBMED Abstract
  218. Nelson KM: Antibody isotype responses and protective immunity resulting from equine influenza virus infection or conventional vaccination, Madison, 1995, University of Wisconsin (Master of Science thesis).
  219. Ainsworth DM, Hackett RP: Disorders of the respiratory system. In Reed SM, Bayly WM, Sellon DC, editor: Equine internal medicine, ed 2, Philadelphia, 2004, Saunders, pp 289–354.
  220. Cheng PK, To AP, Leung TW, et al: Oseltamivir- and amantadine-resistant influenza virus A (H1N1). Emerg Infect Dis 16:155–156, 2009.
  221. Dharan NJ, Gubareva LV, Meyer JJ, et al: Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301:1034–1041, 2009. PUBMED Abstract
  222. Patel A, Gorman SE: Stockpiling antiviral drugs for the next influenza pandemic. Clin Pharmacol Ther 86:241–243, 2009. PUBMED Abstract
  223. Van Voris LP, Newell PM: Antivirals for the chemoprophylaxis and treatment of influenza. Semin Respir Infect 7:61–70, 1992. PUBMED Abstract
  224. Hay AJ: The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein. Semin Virol 3:21, 1992.
  225. Belshe RB, Burk B, Newman F, et al: Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 159:430–435, 1989. PUBMED Abstract
  226. Hayden FG: Antiviral agents, ed 10, New York, 2001, McGraw-Hill.
  227. Shiraishi K, Mitamura K, Sakai-Tagawa Y, et al: High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis 188:57–61, 2003. PUBMED Abstract
  228. Rees WA, Harkins JD, Woods WE, et al: Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J 29:104–110, 1997 (see comment). PUBMED Abstract
  229. Schmidt AC: Antiviral therapy for influenza: a clinical and economic comparative review. Drugs 64:2031–2046, 2004. PUBMED Abstract
  230. Keyser LA, Karl M, Nafziger AN, et al: Comparison of central nervous system adverse effects of amantadine and rimantadine used as sequential prophylaxis of influenza A in elderly nursing home patients. Arch Intern Med 160:1485–1488, 2000. PUBMED Abstract
  231. Rees WA, Harkins JD, Lu M, et al: Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res 60:888–894, 1999. PUBMED Abstract
  232. Hayden FG, Monto AS: Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults. Antimicrob Agents Chemother 29:339–341, 1986. PUBMED Abstract
  233. Van Voris LP, Betts RF, Hayden FG, et al: Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 245:1128–1131, 1981. PUBMED Abstract
  234. Wingfield WL, Pollack D, Grunert RR: Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man. N Engl J Med 281:579–584, 1969. PUBMED Abstract
  235. Hayden FG, Belshe RB, Clover RD, et al: Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med 321:1696–1702, 1989. PUBMED Abstract
  236. Sweet C, Hayden FG, Jakeman KJ, et al: Virulence of rimantadine-resistant human influenza A (H3N2) viruses in ferrets. J Infect Dis 164:969–972, 1991. PUBMED Abstract
  237. Webster RG, Kawaoka Y, Bean WJ: Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus. J Antimicrob Chemother 18(suppl B):157–164, 1986. PUBMED Abstract
  238. Englund JA, Champlin RE, Wyde PR, et al: Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 26:1418–1424, 1998. PUBMED Abstract
  239. Mast EE, Harmon MW, Gravenstein S, et al: Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol 134:988–997, 1991. PUBMED Abstract
  240. Bright RA, Medina M-j, Xu X, et al: Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175–1181, 2005. PUBMED Abstract
  241. Gubareva LV, Kaiser L, Hayden FG: Influenza virus neuraminidase inhibitors. Lancet 355:827–835, 2000. PUBMED Abstract
  242. von Itzstein M, Wu WY, Kok GB, et al: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363:418–423, 1993. PUBMED Abstract
  243. Yamanaka T, Tsujimura K, Kondo T, et al: In vitro efficacies of oseltamivir carboxylate and zanamivir against equine influenza A viruses. J Vet Med Sci 68:405–408, 2006. PUBMED Abstract
  244. Yamanaka T, Yamada M, Tsujimura K, et al: Clinical pharmacokinetics of oseltamivir and its active metabolite oseltamivir carboxylate after oral administration in horses. J Vet Med Sci 69:293–296, 2007. PUBMED Abstract
  245. Yamanaka T, Tsujimura K, Kondo T, et al: Efficacy of oseltamivir phosphate to horses inoculated with equine influenza A virus. J Vet Med Sci 68:923–928, 2006. PUBMED Abstract
  246. Hurt AC, Ernest J, Deng Y-M, et al: Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83:90–93, 2009. PUBMED Abstract
  247. Meijer A, Lackenby A, Hungnes O, et al: Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 15:552–560, 2009. PUBMED Abstract
  248. Moscona A: Global transmission of oseltamivir-resistant influenza. N Engl J Med 360:953–956, 2009. PUBMED Abstract
  249. Mumford JA, Jessett D, Dunleavy U, et al: Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines. Vaccine 12:857–863, 1994. PUBMED Abstract
  250. Mumford JA, Jessett DM, Rollinson EA, et al: Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines. Vet Rec 134:158–162, 1994. PUBMED Abstract
  251. Mumford JA, Wood J: Establishing an acceptability threshold for equine influenza vaccines. Dev Biol Standard 79:137–146, 1992. PUBMED Abstract
  252. Newton JR, Daly JM, Spencer L, et al: Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease. Vet Rec 158:185–192, 2006. PUBMED Abstract
  253. Grogan EH, McDonnell SM: Behavioral responses to two intranasal vaccine applicators in horses and ponies. J Am Vet Med Assoc 226:1689–1693, 2005. PUBMED Abstract
  254. Chambers TM, Holland RE, Tudor LR: A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Vet J 33:630–636, 2001. PUBMED Abstract
  255. Ault A, Zajac AM, Kong W-P, et al: Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies. Vaccine 30:3965–3974, 2012. PUBMED Abstract
  256. Landolt GA, Hussey SB, Kreutzer K, et al: Low-dose DNA vaccination into the submandibular lymph nodes in ponies. Vet Rec 167:302–303, 2010. PUBMED Abstract
  257. Paillot R, Grimmett H, Elton D, et al: Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host. Vet Res 39:21–21, 2008. PUBMED Abstract
  258. Paillot R, Prowse L: ISCOM-matrix-based equine influenza (EIV) vaccine stimulates cell-mediated immunity in the horse. Vet Immunol Immunopathol 145:516–521, 2012. PUBMED Abstract
  259. Lunn DP, Townsend HGG: Equine vaccination. Vet Clin North Am Equine Pract 16:199–226, 2000. PUBMED Abstract
  260. Wilson WD, Kanara E, Spensley MS, et al: Guidelines for vaccination of horses. J Am Vet Med Assoc 207:426–431, 1995.
  261. Wilson WD, Mihalyi JE, Hussey S, et al: Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination. Equine Vet J 33:644–650, 2001. PUBMED Abstract
  262. Terrestrial Animal Health Code, 12th edition, 2004,
  263. Gilkerson JR: Equine influenza in Australia: a clinical overview. Aust Vet J 89:11–13, 2011. PUBMED Abstract
  264. Townsend HGG, Morley PS, Newton JR: Presented at the Equine infectious disease VIII: Proceedings of the Eighth International Conference, Dubai, 1999.
  265. Mumford JA: The equine influenza surveillance program. Adv Vet Med Vet Vaccines Diagnostics 41:379–387, 1999. PUBMED Abstract
  266. Kasel JA, Couch RB: Experimental infection in man and horses with influenza A viruses. Bull WHO 41:447–452, 1969. PUBMED Abstract
  267. Crawford PC, Dubovi EJ, Castleman WL, et al: Transmission of equine influenza virus to dogs. Science 310:482–485, 2005. PUBMED Abstract
  268. Daly JM, Blunden AS, MacRae S, et al: Transmission of equine influenza virus to English foxhounds. Emerg Infect Dis 14:461–464, 2008. PUBMED Abstract
  269. Newton JR, Cooke A, Elton D, et al: Canine influenza virus: cross-species transmission from horses. Vet Rec 161:142–143, 2007. PUBMED Abstract
  270. Kirkland PD, Finlaison DS, Crispe E, et al: Influenza virus transmission from horses to dogs, Australia. Emerg Infect Dis 16:699–702, 2010. PUBMED Abstract
  271. Yamanaka T, Nemoto M, Tsujimura K, et al: Interspecies transmission of equine influenza virus (H3N8) to dogs by close contact with experimentally infected horses. Vet Microbiol 139:351–355, 2009. PUBMED Abstract
  272. Quintana AM, Hussey SB, Burr EC, et al: Evaluation of infectivity of a canine lineage H3N8 influenza A virus in ponies and in primary equine respiratory epithelial cells. Am J Vet Res 72:1071–1078, 2011. PUBMED Abstract
  273. Yamanaka T, Tsujimura K, Kondo T, et al: Infectivity and pathogenicity of canine H3N8 influenza A virus in horses. Influenza Other Respi Viruses 4:345–351, 2010. PUBMED Abstract